Trypanosoma brucei: Lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites

被引:28
作者
Scott, AG
Tait, A
Turner, CMR
机构
[1] UNIV GLASGOW, INST BIOL & LIFE SCI, DIV INFECT & IMMUN, GLASGOW G12 8QQ, LANARK, SCOTLAND
[2] UNIV GLASGOW, ANDERSON COLL, WELCOME UNIT MOL PARASITOL, GLASGOW G11 6NU, LANARK, SCOTLAND
基金
英国惠康基金;
关键词
African trypanosome; drug resistance; melaminophenyl arsenical; adenosine transporter;
D O I
10.1006/expr.1997.4167
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
We have examined cross-resistance between trypanocidal drugs using a well-characterised drug-sensitive Line, 247, and its cymelarsan-resistant derivative, 247melCy(R). The cymelarsan-resistant line was cross-resistant to trimelarsen and melarsen oxide, and partially cross-resistant to two diamidines, pentamidine and berenil (diminazene aceturate). It was cross-resistant to lipid-soluble melarsoprol in vivo but to only a trivial degree in two in vitro assays. The potential role of adenosine transport in arsenical-induced killing of parasites was investigated. Adenosine, adenine, and the diamidines, but not inosine, were able to inhibit killing of drug-sensitive STIB 247 trypanosomes by cymelarsan and melarsen oxide in a concentration-dependent manner. These results are consistent with the view that these arsenical compounds enter trypanosomes via an adenosine-specific transporter. Melarsoprol-induced killing of trypanosomes was unaffected, however, by either purine and to only a slight degree by the diamidines. These data suggest that melarsoprol can enter trypanosomes by a route other than through an adenosine transporter and that there may be two mechanisms contributing to arsenical resistance in this drug-resistant line of trypanosomes. (C) 1997 Academic Press.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 27 条
[1]   A DIAMIDINE-RESISTANT TRYPANOSOMA-EQUIPERDUM CLONE CONTAINS A P2 PURINE TRANSPORTER WITH REDUCED SUBSTRATE AFFINITY [J].
BARRETT, MP ;
ZHANG, ZQ ;
DENISE, H ;
GIROUD, C ;
BALTZ, T .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1995, 73 (1-2) :223-229
[2]   PROPERTIES OF MELARSAMINE HYDROCHLORIDE (CYMELARSAN) IN AQUEOUS-SOLUTION [J].
BERGER, BJ ;
FAIRLAMB, AH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) :1298-1302
[3]   CHARACTERIZATION OF PENTAMIDINE-RESISTANT TRYPANOSOMA-BRUCEI-BRUCEI [J].
BERGER, BJ ;
CARTER, NS ;
FAIRLAMB, AH .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1995, 69 (02) :289-298
[4]  
BRUN R, 1979, ACTA TROP, V36, P289
[5]   PHARMACOKINETIC PROPERTIES OF THE TRYPANOCIDAL DRUG MELARSOPROL [J].
BURRI, C ;
BALTZ, T ;
GIROUD, C ;
DOUA, F ;
WELKER, HA ;
BRUN, R .
CHEMOTHERAPY, 1993, 39 (04) :225-234
[6]  
CARTER NS, 1995, J BIOL CHEM, V270, P28153, DOI 10.1074/jbc.270.47.28153
[7]   ARSENICAL-RESISTANT TRYPANOSOMES LACK AN UNUSUAL ADENOSINE TRANSPORTER [J].
CARTER, NS ;
FAIRLAMB, AH .
NATURE, 1993, 361 (6408) :173-176
[8]  
DE JONGH R. T., 1959, BULL SOC PATHOL EXOT, V52, P769
[9]   THE INTERACTION OF ARSENICAL DRUGS WITH DIHYDROLIPOAMIDE AND DIHYDROLIPOAMIDE DEHYDROGENASE FROM ARSENICAL RESISTANT AND SENSITIVE STRAINS OF TRYPANOSOMA-BRUCEI-BRUCEI [J].
FAIRLAMB, AH ;
SMITH, K ;
HUNTER, KJ .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1992, 53 (1-2) :223-231
[10]   CHARACTERIZATION OF MELARSEN-RESISTANT TRYPANOSOMA-BRUCEI-BRUCEI WITH RESPECT TO CROSS-RESISTANCE TO OTHER DRUGS AND TRYPANOTHIONE METABOLISM [J].
FAIRLAMB, AH ;
CARTER, NS ;
CUNNINGHAM, M ;
SMITH, K .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1992, 53 (1-2) :213-222